Twinox 400 mg/100 mg tablets for dogs

מדינה: אירלנד

שפה: אנגלית

מקור: HPRA (Health Products Regulatory Authority)

מרכיב פעיל:

Amoxicillin (as trihydrate), Clavulanic acid (as potassium clavulanate, diluted : cellulose, microcrystalline(1:1))

זמין מ:

Virbac

קוד ATC:

QJ01CR02

INN (שם בינלאומי):

Amoxicillin (as trihydrate), Clavulanic acid (as potassium clavulanate, diluted : cellulose, microcrystalline(1:1))

כמות:

*** AWAITING VALUE ***

טופס פרצבטיות:

Tablet

סוג מרשם:

POM: Prescription Only Medicine as defined in relevant national legislation

קבוצה תרפויטית:

Dogs

איזור תרפויטי:

amoxicillin and enzyme inhibitor

סממני תרפויטית:

Antibacterial

מצב אישור:

Authorised

תאריך אישור:

2015-07-17

מאפייני מוצר

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Twinox 400 mg/100 mg tablets for dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCES
Amoxicillin (as amoxicillin trihydrate)
400 mg
Clavulanic acid (as potassium clavulanate)
100 mg
EXCIPIENTS
Erythrosine (E127)
0.5 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet.
Pale pink, rounded, one side scored, uncoated and divisible tablet.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections caused by micro-organisms sensitive to the
combination amoxicillin/clavulanic acid, especially:
- dermatitis (superficial and deep pyoderma) caused by_ Staphylococcus
(pseud)intermedius_.
- urinary tract infections caused by_ E. coli_ and_ Staphylococcus_
spp.
- respiratory tract infections caused by_ Streptococcus_ spp.
- enteritis caused by_ E. coli_.
4.3 CONTRAINDICATIONS
- Do not use in animals with known hypersensitivity to penicillin or
other substances of the
beta-lactam group or to any of the excipients.
- Do not use in case of serious dysfunction of the kidneys accompanied
by anuria and oliguria.
- Do not use in rabbits, guinea pigs, hamsters, chinchillas or gerbils
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_9_
_/_
_0_
_8_
_/_
_2_
_0_
_1_
_5_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_1_
_5_
_0_
_0_
_p_
_a_
_g_
_e_
_ _
_n_
_